GO FUND IT NOW

IRISYS, INC.

THIS TASK ORDER (TO) IS TO PROVIDE DOSAGE FORM DEVELOPMENT, MANUFACTURE AND STABILITY STUDIES OF ORC-13661 FOR PHASE II CLINICAL TRIAL

THIS TASK ORDER (TO) IS TO PROVIDE DOSAGE FORM DEVELOPMENT, MANUFACTURE AND STABILITY STUDIES OF ORC-13661 FOR PHASE II CLINICAL TRIAL is a funding opportunity from IRISYS, INC., up to 180000, closing July 31, 2027.

Funder
IRISYS, INC.
Funding
180000
Deadline
Jul 31, 2027
(365d left)

Overview

Dosage Form Development, Manufacture and Stability Studies of ORC-13661 for Phase II Clinical Trial

THIS TASK ORDER (TO) IS TO PROVIDE DOSAGE FORM DEVELOPMENT, MANUFACTURE AND STABILITY STUDIES OF ORC-13661 FOR PHASE II CLINICAL TRIAL | Go Fund It Now